Your browser doesn't support javascript.
loading
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex.
Yazdi, Aliakbar Khalili; Perveen, Sumera; Dong, Cheng; Song, Xiaosheng; Dong, Aiping; Szewczyk, Magdalena M; Calabrese, Matthew F; Casimiro-Garcia, Agustin; Chakrapani, Subramanyam; Dowling, Matthew S; Ficici, Emel; Lee, Jisun; Montgomery, Justin I; O'Connell, Thomas N; Skrzypek, Grzegorz J; Tran, Tuan P; Troutman, Matthew D; Wang, Feng; Young, Jennifer A; Min, Jinrong; Barsyte-Lovejoy, Dalia; Brown, Peter J; Santhakumar, Vijayaratnam; Arrowsmith, Cheryl H; Vedadi, Masoud; Owen, Dafydd R.
Afiliação
  • Yazdi AK; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Perveen S; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Dong C; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Song X; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Dong A; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Szewczyk MM; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Calabrese MF; Pfizer Research & Development Groton CT USA.
  • Casimiro-Garcia A; Pfizer Research & Development Cambridge MA USA dafydd.owen@pfizer.com.
  • Chakrapani S; Pfizer Research & Development Groton CT USA.
  • Dowling MS; Pfizer Research & Development Groton CT USA.
  • Ficici E; Pfizer Research & Development Groton CT USA.
  • Lee J; Pfizer Research & Development Groton CT USA.
  • Montgomery JI; Pfizer Research & Development Groton CT USA.
  • O'Connell TN; Pfizer Research & Development Groton CT USA.
  • Skrzypek GJ; Pfizer Research & Development Groton CT USA.
  • Tran TP; Pfizer Research & Development Groton CT USA.
  • Troutman MD; Pfizer Research & Development Groton CT USA.
  • Wang F; Pfizer Research & Development Groton CT USA.
  • Young JA; Pfizer Research & Development Groton CT USA.
  • Min J; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Barsyte-Lovejoy D; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Brown PJ; Department of Pharmacology and Toxicology, University of Toronto Toronto ON Canada.
  • Santhakumar V; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Arrowsmith CH; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Vedadi M; Structural Genomics Consortium, University of Toronto Toronto ON Canada.
  • Owen DR; Department of Pharmacology and Toxicology, University of Toronto Toronto ON Canada.
RSC Med Chem ; 15(3): 1066-1071, 2024 Mar 20.
Article em En | MEDLINE | ID: mdl-38516600
ABSTRACT
We have developed a novel chemical handle (PFI-E3H1) and a chemical probe (PFI-7) as ligands for the Gid4 subunit of the human E3 ligase CTLH degradation complex. Through an efficient initial hit-ID campaign, structure-based drug design (SBDD) and leveraging the sizeable Pfizer compound library, we identified a 500 nM ligand for this E3 ligase through file screening alone. Further exploration identified a vector that is tolerant to addition of a linker for future chimeric molecule design. The chemotype was subsequently optimized to sub-100 nM Gid4 binding affinity for a chemical probe. These novel tools, alongside the suitable negative control also identified, should enable the interrogation of this complex human E3 ligase macromolecular assembly.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article